Ascendis Pharma
ASND
#1652
Rank
C$17.78 B
Marketcap
C$291.07
Share price
-1.75%
Change (1 day)
57.12%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2025 (TTM): C-$6.08

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is C-$5.86. In 2024 the company made an earnings per share (EPS) of C-$9.70 an increase over its 2023 EPS that were of C-$12.62.

EPS history for Ascendis Pharma from 2023 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$6.08-37.33%
2024C-$9.70-23.17%
2023C-$12.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
C-$0.09540-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
C-$7.12 21.47%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
C-$13.21 125.17%๐Ÿ‡บ๐Ÿ‡ธ USA